You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -1,342.5% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -0.4 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 4.6 | n/a |
Price / Book value | 0.5 |
Latest | Forecast | |
---|---|---|
Revenue | 31.5% | 15.4% |
PBT | 0.0% | n/a |
EPS | 0.0% | -40.6% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-03-31 | 0.05 | -17.23 | -44.11p | -2.3 | 0.0 | n/a | n/a | 0.0% |
2020-03-31 | 6.07 | -13.86 | -34.96p | -2.8 | 0.0 | n/a | n/a | 0.0% |
2021-03-31 | 0.26 | -13.41 | -29.00p | -4.1 | 0.0 | n/a | n/a | 0.0% |
2022-03-31 | 0.40 | -11.06 | -17.00p | -1.8 | 0.0 | n/a | n/a | 0.0% |
2023-03-31 | 0.53 | -6.66 | -9.50p | -1.0 | 0.0 | n/a | n/a | 0.0% |
ReNeuron reaches exosome research milestone Sharecast News | 04 Sep |
---|---|
Director dealings: Reneuron CFO makes share purchase Sharecast News | 24 Jan |
ReNeuron shares tumble after first-half results Sharecast News | 02 Dec |
Interim Results for the six months ended 30 Sept | 08-Nov-23 07:01 |
---|---|
ReNeuron presents in vivo data at Cell 2023 | 08-Nov-23 07:00 |
R&D Update | 04-Sep-23 14:10 |
Block Listing Review & Total Voting Rights | 01-Sep-23 14:27 |